Europe tissue banking market accounted for $5,445.7 million in 2020 and will grow by 7.2% annually over 2020-2030 owing to the increasing demand for regenerative medicines and advancements in tissue preservation and in-house sample testing, an increasing number of biobanks across the globe, and the advancements in the medical drug discovery and biopharmaceuticals industry.
Highlighted with 34 tables and 60 figures, this 118-page report Europe Tissue Banking Market 2020-2030 by Offering (Equipment, Accessories & Consumables, Services), Application (Therapeutics, Medical Research, Cosmetics), Tissue Type (Cardiovascular, Corneal, Lung, Kidney, Bone, Skin), End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Europe tissue banking market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe tissue banking market in every aspect of the classification from perspectives of Offering, Application, Tissue Type, End User, and Country.

Based on Offering, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Equipment
o Cryopreservation Equipment
o Thawing Equipment
o Quality Control Equipment
o Labeling and Coding Equipment
o Alarming and Monitoring Systems
o Other Equipment
Accessories and Consumables
Services
o Screening
o Processing
o Tissue Retrieval
o Testing
o Storage and Preservation
o Other Services

Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Therapeutics
Medical Research
Cosmetics
Other Applications

Based on Tissue Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Cardiovascular Tissue
Corneal Tissue
Lungs Tissue
Kidney Tissue
Bone Tissue
Skin Tissue
Brain & Spinal Cord
Others Tissue Types

Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.
Biobanks
Hospitals and Clinics
Research and Academic Institutes
Other End Users

Geographically, the following national/local markets are fully investigated:
Germany
UK
France
Spain
Italy
Russia
Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Offering, Application, and Tissue Type over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AMS Biotechnology Ltd.
Avantor Inc. (VWR International)
Beckman Coulter, Inc.
Bio-Rad Laboratories Inc.
Bluechiip Limited
Brooks Lifesciences (Brooks Automation Inc.)
Custom Biogenic Systems, Inc.
Eppendorf AG
Hamilton Company
Merck KGaA
Organ Recovery Systems, Inc.
PHC Holdings Corporation
Sartorius AG
Taylor-Wharton International LLC
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)